-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Pear Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q4 2022.
- Pear Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was -$26.4M, a 241% decline year-over-year.
- Pear Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was -$75.5M, a 15.9% decline year-over-year.
- Pear Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$75.5M, a 15.9% decline from 2021.
- Pear Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$65.1M, a 32.9% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)